Evogene (EVGN) Price & Analysis

Compare

630 Followers

EVGN Stock Chart & Stats

Day’s Range― - ―

52-Week Range$0.95 - $4.45

Previous CloseN/A

Volume47.40K

Average Volume (3M)102.66K

Market Cap

$11.76M

Enterprise Value$17.28M

Total Cash (Recent Filing)$15.31M

Total Debt (Recent Filing)$12.87M

Price to Earnings (P/E)―

Beta1.08

Next Earnings

Aug 19, 2025

EPS Estimate

-0.63

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.38

Shares Outstanding8,714,230

10 Day Avg. Volume68,757

30 Day Avg. Volume102,662

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market Cap1.47

Enterprise Value/Revenue2.03

Enterprise Value/Gross Profit3.31

Enterprise Value/Ebitda-1.12

Forecast

1Y Price Target

$3.50

Price Target Upside159.26% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

Bulls Say, Bears Say

Bulls Say

Cost ManagementCost controls have appropriately been implemented, leading to a lower than expected operating expense and an EBITDA beat despite lower revenues.

Potential GrowthCasterra is believed to be a potential catalyst for the stock via commercial successes, with material value also seen in AgPlenus and Lavie Bio.

Bears Say

Order DelaysDelays in current order delivery and a follow-on order continue to be a material headwind for investors.

Order VisibilityThere is little visibility of a follow-on order at Casterra, which was expected to be a significant commercial catalyst.

Stock DilutionThe diluted share base effectively doubled due to a $5.5M raise, contributing to the decision to lower the price target.

Evogene News

Evogene Updates Proxy Card for August 2025 Shareholder Meeting

Evogene ( ($EVGN) ) has provided an announcement. Evogene Ltd., an Israeli company, has announced an update regarding...

21d ago

EVGN

Evogene Completes Sale of Lavie Bio’s Activities to ICL

Evogene ( ($EVGN) ) has shared an update. On July 8, 2025, Evogene Ltd. announced the completion of...

1M ago

EVGN

Evogene Announces Annual General Meeting for August 2025

Evogene ( ($EVGN) ) has shared an update. Evogene Ltd. has announced its upcoming Annual General Meeting of...

2M ago

EVGN

Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories

It’s time to dive into the biggest stock market stories that traders need to know about on Tuesday. ...

2M ago

BTC

Evogene announces completion of generative AI foundation model with Google Cloud

Evogene (EVGN) announced the completion of its generative AI foundation model, version 1.0, for small molecule design, developed...

2M ago

EVGN

GOOG

Evogene price target lowered to $3.50 from $6 at Alliance Global Partners

Alliance Global Partners analyst Scott Henry lowered the firm’s price target on Evogene (EVGN) to $3.50 from $6...

2M ago

EVGN

Evogene Announces Leadership Change and Strategic Shift at Biomica

Evogene ( ($EVGN) ) has issued an announcement. Evogene Ltd. announced a significant management change in its subsidiary,...

2M ago

EVGN

Evogene Ltd. Earnings Call: Balancing Growth and Challenges

Evogene Ltd. (($EVGN)) has held its Q1 earnings call. Read on for the main highlights of the call....

3M ago

EVGN

Evogene price target lowered to $3.50 from $5 at Lake Street

Lake Street analyst Ben Klieve lowered the firm’s price target on Evogene (EVGN) to $3.50 from $5 and...

3M ago

EVGN

Evogene Ltd. Reports Q1 2025 Financial Results

Evogene Ltd. ( ($EVGN) ) has released its Q1 earnings. Here is a breakdown of the information Evogene...

3M ago

EVGN

Evogene Announces Q1 2025 Financial Results and Strategic Acquisition

Evogene ( ($EVGN) ) has shared an update. On May 21, 2025, Evogene Ltd. announced its financial results...

3M ago

EVGN

Evogene reports Q1 EPS (38c) vs. (76c) last year

Reports Q1 revenue 2.4M vs. $4.2M last year. Q1 of FY24 revenue included license fee payments totaling $3.5M-$2.5M...

3M ago

EVGN

EVGN Upcoming Earnings Report: What to Expect?

Evogene Ltd. (EVGN) is scheduled to report 1st quarter earnings on 05/21/2025, before the market opens. Regarding Q1...

3M ago

EVGN

Biotech Alert: Searches spiking for these stocks today

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by...

4M ago

APVO

DWTX

EVGN FAQ

What was Evogene Ltd.’s price range in the past 12 months?

Evogene Ltd. lowest stock price was $0.95 and its highest was $4.45 in the past 12 months.

What is Evogene Ltd.’s market cap?

Evogene Ltd.’s market cap is $11.76M.

When is Evogene Ltd.’s upcoming earnings report date?

Evogene Ltd.’s upcoming earnings report date is Aug 19, 2025 which is in 11 days.

How were Evogene Ltd.’s earnings last quarter?

Evogene Ltd. released its earnings results on May 21, 2025. The company reported -$0.38 earnings per share for the quarter, beating the consensus estimate of -$0.505 by $0.125.

Is Evogene Ltd. overvalued?

According to Wall Street analysts Evogene Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Evogene Ltd. pay dividends?

Evogene Ltd. does not currently pay dividends.

What is Evogene Ltd.’s EPS estimate?

Evogene Ltd.’s EPS estimate is -0.63.

How many shares outstanding does Evogene Ltd. have?

Evogene Ltd. has 8,714,230 shares outstanding.

What happened to Evogene Ltd.’s price movement after its last earnings report?

Evogene Ltd. reported an EPS of -$0.38 in its last earnings report, beating expectations of -$0.505. Following the earnings report the stock price went down -7.087%.

Which hedge fund is a major shareholder of Evogene Ltd.?

Currently, no hedge funds are holding shares in EVGN

Company Description

Evogene Ltd.

Evogene Ltd. is an Israeli biotechnology company that focuses on developing and utilizing computational biology technologies to enhance the productivity and sustainability of agriculture. Operating in sectors such as ag-biologicals, ag-chemicals, seed traits, and human microbiome therapeutics, Evogene leverages its proprietary AI-driven platform, the CPB (Computational Predictive Biology), to innovate solutions that address critical challenges in agriculture and human health.

Evogene (EVGN) Earnings & Revenues

Historic Earnings Reports

EVGN Earnings Call

Q1 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The earnings call highlighted Evogene's strategic efforts to reduce expenses and successfully execute acquisitions, leading to a more sustainable financial position. However, it also revealed a significant revenue decline and the need for additional funding for certain projects, balancing out the positive achievements.View all EVGN earnings summaries

EVGN Stock 12 Month Forecast

Average Price Target

$3.50

▲(159.26% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","2":"$2","4":"$4","6":"$6","8":"$8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$3.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$3.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$3.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,2,4,6,8],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Dec<br/>2024","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.34,1.5061538461538462,1.6723076923076925,1.8384615384615386,2.0046153846153847,2.170769230769231,2.336923076923077,2.5030769230769234,2.6692307692307695,2.8353846153846156,3.0015384615384617,3.167692307692308,3.333846153846154,{"y":3.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.34,1.5061538461538462,1.6723076923076925,1.8384615384615386,2.0046153846153847,2.170769230769231,2.336923076923077,2.5030769230769234,2.6692307692307695,2.8353846153846156,3.0015384615384617,3.167692307692308,3.333846153846154,{"y":3.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.34,1.5061538461538462,1.6723076923076925,1.8384615384615386,2.0046153846153847,2.170769230769231,2.336923076923077,2.5030769230769234,2.6692307692307695,2.8353846153846156,3.0015384615384617,3.167692307692308,3.333846153846154,{"y":3.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7.8,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.16,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.45,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.87,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.13,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.24,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.6,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.87,"date":1735689600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.46,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.25,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.15,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.09,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.34,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >